<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="82626">
  <stage>Registered</stage>
  <submitdate>11/04/2008</submitdate>
  <approvaldate>17/04/2008</approvaldate>
  <actrnumber>ACTRN12608000206325</actrnumber>
  <trial_identification>
    <studytitle>2008 weight loss diets and resistance exercise training in type 2 diabetes study</studytitle>
    <scientifictitle>A randomised study to evaluate High protein diets and resistance exercise training in type 2 diabetes study 2008</scientifictitle>
    <utrn />
    <trialacronym>PE</trialacronym>
    <secondaryid>LZ46a issued by the Commonwealth Scientific and Industrial Research Organisation</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Obesity</healthcondition>
    <healthcondition>Type 2 Diabetes</healthcondition>
    <conditioncode>
      <conditioncode1>Diet and nutrition</conditioncode1>
      <conditioncode2>Obesity</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>16 week low fat (20% of energy) weight loss diet intervention of either high carbohydrate (55%) or high protein (35%) dietary composition. 3 of 5 groups will also participate in a whole body moderate intensity resistance exercise training program. Training sessions of 30 minutes duration held 3 times per week for 16 weeks.</interventions>
    <comparator>16 week high carbohydrate (55% of total energy) weight loss diet with and without an exercise program. Training sessions of 30 minutes duration held 3 times per week for 16 weeks.</comparator>
    <control>Active</control>
    <interventioncode>Lifestyle</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Whole Body Composition by DEXA (dual energy x-ray absorptiometry) scan.</outcome>
      <timepoint>Week 0 (baseline) and Week 16.</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Glycaemic Control (Haemoglobin A1C (HBA1c), Glucose, Insulin from fasting venous blood sample)</outcome>
      <timepoint>Week 0 (baseline) and Week 16.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Cardiovascular Disease Risk (Blood Lipid Profile, Blood Pressure, Abdominal fat/waist circumference)</outcome>
      <timepoint>Week 0 (baseline) and Week 16.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Male or female
Age between 18-65 years
BMI (body mass index) not greater than 40 or less than 27 (calculated for the volunteers by the research staff based on weight (kg) divided by height (m) squared)
Have type 2 diabetes (HbA1c &lt; 7.0% or previously diagnosed and controlled with medication)
Not have type 1 diabetes
Participants must understand the procedures involved and agree to participate in the study by giving full informed, written consent
No abnormality of clinical significance on medical history
If female, not pregnant or breast feeding</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>65</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>BMI(body mass index) greater than 40 or less than 27
Not have type 2 diabetes (HbA1c &lt; 7.0% or not previously diagnosed and controlled with medication)
Lactose Intolerant
Taking Insulin medication
Have been previously diagnosed with proteinuria, a malignancy, or metabolic disease such as liver, kidney, respiratory, gastrointestinal disease or stroke, or are pregnant or lactating
Have been previously diagnosed with cardiac disease, including myocardial ischemia or major heart rhythm abnormalities.   
Have high uncontrolled hypertension (resting recumbent BP &gt;160/100 mmHg)
Have a musculoskeletal injury, joint or peripheral vascular disease sufficient to impede exercise (such as hip arthritis, foot, ankle problems or pain)
Have severe exercise-induced asthma
History of smoking during 6 months prior to study
History of heavy alcohol consumption (&gt; 5 STD drinks/day) 
Volunteer unable to cease alcohol consumption for study duration
Participated in regular aerobic or resistance exercise program (greater than two 30-min sessions of moderate/vigorous aerobic exercise per week or greater than 1 moderate intensity resistance exercise session per week) during the 6 months prior to study
Widely fluctuating exercise patterns
Currently on a weight reducing diet
Unwilling to be randomized to either experimental group
Extended absences due to travel or other commitments
Unable to comprehend or cope with study requirements
Unable to eat pork and ham on 4 occasions per week
Unwilling to be randomised to a non-exercise arm</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Subjects are screened for inclusion and exclusion criteria and once deemed eligible are randomly allocated into one of 5 lifestyle intervention groups. Central randomisation by computer.</concealment>
    <sequence>Random allocation using computer software "Clinstat"</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate>3/03/2008</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>100</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
    <postcode>5000</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Government body</primarysponsortype>
    <primarysponsorname>Commonwealth Scientific and Industrial Research Organisation (CSIRO) Human Nutrition</primarysponsorname>
    <primarysponsoraddress>Gate 13
Kintore Ave
Adelaide SA 5000</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Pork Cooperative Research Centre</fundingname>
      <fundingaddress>Level 1
Eastick Building 
University of Adelaide 
Roseworthy Campus 
Mudla Wirra Rd, Roseworthy
SA 5371
(there is no street number)</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>CSIRO Human Research Ethics Committee</ethicname>
      <ethicaddress>Gate 13
Kintore Ave
Adelaide SA 5000</ethicaddress>
      <ethicapprovaldate>14/12/2007</ethicapprovaldate>
      <hrec>07/34</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>CSIRO Human Research Ethics Committee</ethicname>
      <ethicaddress>Gate 13
Kintore Ave
Adelaide SA 5000</ethicaddress>
      <ethicapprovaldate>14/12/2007</ethicapprovaldate>
      <hrec>07/34</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr Grant Brinkworth</name>
      <address>CSIRO Human Nutrition
Gate 13
Kintore Ave
Adelaide SA 5000</address>
      <phone>+61 83038830</phone>
      <fax>+61 83038899</fax>
      <email>grant.brinkworth@csiro.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Anne McGuffin</name>
      <address>CSIRO Human Nutrition
Gate 13
Kintore Ave
Adelaide SA 5000</address>
      <phone>+61 83038988</phone>
      <fax>+61 83038899</fax>
      <email>anne.mcguffin@csiro.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Grant Brinkworth</name>
      <address>CSIRO Human Nutrition
Gate 13
Kintore Ave
Adelaide SA 5000</address>
      <phone>+61 83038830</phone>
      <fax>+61 83038899</fax>
      <email>grant.brinkworth@csiro.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>